Raymond James & Associates’s Molina Healthcare MOH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $14.6M | Buy |
42,298
+15,840
| +60% | +$5.23M | 0.01% | 998 |
|
|
2024
Q2 | $7.87M | Sell |
26,458
-5,050
| -16% | -$1.71M | 0.01% | 1304 |
|
|
2024
Q1 | $12.9M | Sell |
31,508
-3,706
| -11% | -$1.44M | 0.01% | 1017 |
|
|
2023
Q4 | $12.7M | Sell |
35,214
-72
| -0.2% | -$25.4K | 0.01% | 966 |
|
|
2023
Q3 | $11.6M | Buy |
35,286
+34
| +0.1% | +$10.7K | 0.01% | 962 |
|
|
2023
Q2 | $10.6M | Buy |
35,252
+15,436
| +78% | +$4.44M | 0.01% | 1018 |
|
|
2023
Q1 | $5.3M | Sell |
19,816
-7,523
| -28% | -$2.16M | ﹤0.01% | 1423 |
|
|
2022
Q4 | $9.03M | Sell |
27,339
-3,721
| -12% | -$1.26M | 0.01% | 1051 |
|
|
2022
Q3 | $10.2M | Sell |
31,060
-11,349
| -27% | -$3.65M | 0.01% | 953 |
|
|
2022
Q2 | $11.9M | Buy |
42,409
+3,309
| +8% | +$1,000K | 0.01% | 879 |
|
|
2022
Q1 | $13M | Buy |
39,100
+1,087
| +3% | +$335K | 0.01% | 931 |
|
|
2021
Q4 | $12.1M | Buy |
38,013
+6,029
| +19% | +$1.79M | 0.01% | 991 |
|
|
2021
Q3 | $8.68M | Sell |
31,984
-103
| -0.3% | -$27.2K | 0.01% | 1134 |
|
|
2021
Q2 | $8.12M | Sell |
32,087
-1,946
| -6% | -$489K | 0.01% | 1189 |
|
|
2021
Q1 | $7.96M | Sell |
34,033
-2,803
| -8% | -$625K | 0.01% | 1157 |
|
|
2020
Q4 | $7.83M | Sell |
36,836
-4,023
| -10% | -$831K | 0.01% | 1091 |
|
|
2020
Q3 | $7.48M | Buy |
40,859
+550
| +1% | +$100K | 0.01% | 1007 |
|
|
2020
Q2 | $7.17M | Buy |
40,309
+3,408
| +9% | +$580K | 0.01% | 985 |
|
|
2020
Q1 | $5.16M | Buy |
36,901
+9,921
| +37% | +$1.33M | 0.01% | 1034 |
|
|
2019
Q4 | $3.66M | Sell |
26,980
-806
| -3% | -$102K | ﹤0.01% | 1457 |
|
|
2019
Q3 | $3.05M | Buy |
27,786
+6,954
| +33% | +$901K | ﹤0.01% | 1543 |
|
|
2019
Q2 | $2.98M | Sell |
20,832
-935
| -4% | -$128K | ﹤0.01% | 1545 |
|
|
2019
Q1 | $3.09M | Buy |
21,767
+6,793
| +45% | +$919K | ﹤0.01% | 1493 |
|
|
2018
Q4 | $1.74M | Buy |
14,974
+10,996
| +276% | +$1.44M | ﹤0.01% | 1746 |
|
|
2018
Q3 | $592K | Buy |
3,978
+140
| +4% | +$17.9K | ﹤0.01% | 2595 |
|
|
2018
Q2 | $376K | Buy |
+3,838
| New | +$335K | ﹤0.01% | 2873 |
|
|
2017
Q1 | – | Sell |
-33,656
| Closed | -$1.83M | – | 3354 |
|
|
2016
Q4 | $1.83M | Sell |
33,656
-1,612
| -5% | -$88.2K | ﹤0.01% | 1544 |
|
|
2016
Q3 | $2.06M | Sell |
35,268
-74
| -0.2% | -$4.08K | 0.01% | 1437 |
|
|
2016
Q2 | $1.76M | Sell |
35,342
-28,518
| -45% | -$1.52M | 0.01% | 1403 |
|
|
2016
Q1 | $4.12M | Sell |
63,860
-12,600
| -16% | -$748K | 0.01% | 914 |
|
|
2015
Q4 | $4.6M | Sell |
76,460
-1,793
| -2% | -$113K | 0.02% | 843 |
|
|
2015
Q3 | $5.39M | Buy |
78,253
+5,457
| +7% | +$405K | 0.02% | 707 |
|
|
2015
Q2 | $5.12M | Buy |
72,796
+3,002
| +4% | +$201K | 0.02% | 805 |
|
|
2015
Q1 | $4.7M | Sell |
69,794
-7,927
| -10% | -$458K | 0.02% | 772 |
|
|
2014
Q4 | $4.16M | Buy |
77,721
+28,235
| +57% | +$1.37M | 0.02% | 763 |
|
|
2014
Q3 | $2.09M | Buy |
49,486
+3,668
| +8% | +$162K | 0.01% | 1079 |
|
|
2014
Q2 | $2.04M | Buy |
45,818
+290
| +0.6% | +$11.8K | 0.01% | 1088 |
|
|
2014
Q1 | $1.71M | Buy |
45,528
+1,771
| +4% | +$65.3K | 0.01% | 1120 |
|
|
2013
Q4 | $1.52M | Buy |
43,757
+11,352
| +35% | +$382K | 0.01% | 1093 |
|
|
2013
Q3 | $1.15M | Buy |
32,405
+1,422
| +5% | +$52.5K | 0.01% | 1173 |
|
|
2013
Q2 | $1.15M | Buy |
+30,983
| New | +$1.09M | 0.01% | 1098 |
|
Other funds holding MOH
Raymond James & Associates's MOH Position: Q3 2024 in Review
Raymond James & Associates increased its Molina Healthcare (MOH) stake by 60% in Q3 2024, buying an estimated $5.23M and bringing the position to 42,298 shares worth $14.6M. The position accounts for 0.01% of the portfolio, ranked #998.
Raymond James & Associates first reported a position in MOH in Q2 2013 and has held it in 41 quarters since. 617 funds tracked by Wall St. Rank hold MOH as of Q3 2024.
- Raymond James & Associates held 42,298 shares of Molina Healthcare worth $14.6M as of Q3 2024.
- Raymond James & Associates bought 15,840 Molina Healthcare shares in Q3 2024, an estimated $5.23M.
- Molina Healthcare made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #998 holding.
- Raymond James & Associates first reported a position in Molina Healthcare in Q2 2013 and has held it in 41 quarters since.
- 617 funds tracked by Wall St. Rank held Molina Healthcare as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.